Bioanalysis and pharmacokinetics of the p38 MAPkinase inhibitor SB202190 in rats
Jai Prakash(Radboud University Nijmegen), Robbert J. Kok(Utrecht University), Klaas Poelstra(University of Groningen), Jan Visser, Dirk K. F. Meijer(University of Groningen), Frits Moolenaar(University of Groningen), Vinay Saluja(University of Groningen)
Cited by 8
Related Papers
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285